Why Now

Modern medicine is filled with stories of fights that seemed unwinnable - until we won. Just as previous generations defeated polio and smallpox, we're creating our own legacy: a future without Alzheimer's disease.

Stopping an Epidemic

Here's why Alzheimer's research is so important:

why now infogrpahic

*source: Alzheimer's Association. Alzheimer's Disease Facts & Figures

The facts are startling, but we can change them. By joining the Alzheimer’s Prevention Registry, you have the power to help make it happen.

Scientists are Doing their Part

We've learned a tremendous amount about Alzheimer's in just the past decade.

  • We now have a much better idea of how disease develops and how it progresses.

  • We're learning more about genes, lifestyle and other factors that influence whether or not someone develops Alzheimer's.

  • We're even learning about how it might be prevented.

Because of these new insights, researchers are now launching a wave of new Alzheimer's prevention trials. But right now, 80 percent of studies are delayed because too few people sign up to participate.

Can We Count on You?

That's where you come in -- when you join the Registry, we'll connect you with studies that need participants like you. You are under no obligation to join any studies, of course, and your information will remain safe and secure.

Learn more about how the Registry works and why it's so important to join.

Advance the research.  Support the scientists.  Spread the word. Join the Registry.

Recent News
older active friends_cropped
A decline in dementia could be linked to healthier arteries
Recent articles have reported a possible decline in dementia. What is causing it? Researchers examined data from more than 1500 brain autopsies to find out. The results could help scientists better understand the link between Alzheimer’s disease and cardiovascular health.
Happy senior man cropped
Rare gene mutation delays onset of early Alzheimer’s by 30 years

A brother and sister in Medellin, Colombia benefitted from a rare gene mutation that protected them from developing the early onset Alzheimer’s disease that is rampant in their extended family. How did this gene stave off symptoms for so long? And how is it related to the case of a distant relative, discovered four years ago, whose cognitive decline was delayed 30 years by a different gene mutation? 

MRI Image scan review shutterstock_cropped
Almost half of participants in anti-amyloid study show no disease progression in one year
Eli Lilly recently announced positive results for their Trailblazer-ALZ 2 Phase 3 clinical trial. The drug donanemab slowed cognitive and functional decline in a significant portion of study participants diagnosed with early-stage Alzheimer’s disease. This is the third drug reported to show a link between amyloid plaque clearance and lessening the progression of disease symptoms.